Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nymox takes AlzheimAlert urine test kit to EU:

This article was originally published in Clinica

Executive Summary

Nymox Pharmaceutical has CE-marked for sale in Europe its urine test kit for helping to diagnose Alzheimer's disease. AlzheimAlert measures the level of the brain protein NTP (neural thread protein), which the Maywood, New Jersey firm says is found in higher amounts in the urine of patients suffering from the disease. A premarket approval (PMA) application to market the test in the US was recently turned down by the FDA, after the agency said that issues concerning the company's clinical study methodology meant that it could not approve the PMA in its current form. The FDA's decision did not restrict Nymox' ability to market and sell AlzheimAlert under CLIA regulations; the test is marketed as a clinical reference laboratory service provided by its government-inspected clinical reference laboratory in New Jersey.

You may also be interested in...

US FDA Not Changing Assessment Goals Because of Coronavirus-Mandated Telework

Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts